Predictive Oncology Inc. — Director's Dealing 2012

Apr 24, 2012

SEC Form 3/A — Form 3/A

Issuer: BioDrain Medical, Inc. (BIOR)
CIK: 0001446159
Period of Report: 2011-12-28

Reporting Person: Herschkowitz Samuel (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.01 per share	1588667	Direct

Footnotes

F1: Pursuant to the Amended and Restated Note Purchase Agreement, dated as of December 20, 2011, between the Issuer and Dr. Herschkowitz (the "First Note Purchase Agreement"), in exchange for a loan in the amount of $240,000, the Issuer issued to Dr. Herschkowitz a Convertible Promissory Note (the "First Note") in the principal amount of $240,000. Pursuant to the First Note Purchase Agreement, the Issuer agreed to issue an equity bonus to Dr. Herschkowitz in an amount based upon the outstanding principal amount under the First Note. Prior to being amended and restated, the First Note was issued in the original principal amount of $225,000. Upon amending and restating the First Note, the principal amount was increased to $240,000. 1,546,667 of the shares reported in Table I constitute an equity bonus issued pursuant to the First Note Purchase Agreement for the $225,000 original principal amount under the First Note. The shares were issued at a valuation of $0.15 per share.